Literature DB >> 32335802

Biological properties and clinical applications of berberine.

Danyang Song1, Jianyu Hao2, Daiming Fan3,4.   

Abstract

Berberine, an isoquinoline alkaloid isolated from the Chinese herb Coptis chinensis and other Berberis plants, has a wide range of pharmacological properties. Berberine can be used to treat many diseases, such as cancer and digestive, metabolic, cardiovascular, and neurological diseases. Berberine has protective capacities in digestive diseases. It can inhibit toxins and bacteria, including Helicobacter pylori, protect the intestinal epithelial barrier from injury, and ameliorate liver injury. Berberine also inhibits the proliferation of various types of cancer cells and impedes invasion and metastasis. Recent evidence has confirmed that berberine improves the efficacy and safety of chemoradiotherapies. In addition, berberine regulates glycometabolism and lipid metabolism, improves energy expenditure, reduces body weight, and alleviates nonalcoholic fatty liver disease. Berberine also improves cardiovascular hemodynamics, suppresses ischemic arrhythmias, attenuates the development of atherosclerosis, and reduces hypertension. Berberine shows potent neuroprotective effects, including antioxidative, antiapoptotic, and anti-ischemic. Furthermore, berberine exerts protective effects against other diseases. The mechanisms of its functions have been extensively explored, but much remains to be clarified. This article summarizes the main pharmacological actions of berberine and its mechanisms in cancer and digestive, metabolic, cardiovascular, and neurological diseases.

Entities:  

Keywords:  Coptis chinensis; berberine; clinical applications; mechanism; pharmacological properties

Mesh:

Substances:

Year:  2020        PMID: 32335802     DOI: 10.1007/s11684-019-0724-6

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  37 in total

1.  Mechanism of berberine hydrochloride interfering with biofilm formation of Hafnia alvei.

Authors:  Yuesheng Pang; Sha Wang; Jiayue Tao; Jing Wang; Zhe Xue; Rufeng Wang
Journal:  Arch Microbiol       Date:  2022-01-08       Impact factor: 2.552

2.  Synergistic inhibitory effect of berberine and icotinib on non-small cell lung cancer cells via inducing autophagic cell death and apoptosis.

Authors:  Ping Chen; Chun-Hua Dai; Zhi-Hao Shi; Yi Wang; Jian-Nong Wu; Kang Chen; Jin-Yu Su; Jian Li
Journal:  Apoptosis       Date:  2021-11-07       Impact factor: 4.677

3.  Neuroprotective Effect and Possible Mechanisms of Berberine in Diabetes-Related Cognitive Impairment: A Systematic Review and Meta-Analysis of Animal Studies.

Authors:  Yanwei Hao; Jiaxin Li; Shengnan Yue; Shaofeng Wang; Shuangyuan Hu; Bin Li
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

Review 4.  Recent Advances in Managing Spinal Intervertebral Discs Degeneration.

Authors:  Bogdan Costăchescu; Adelina-Gabriela Niculescu; Raluca Ioana Teleanu; Bogdan Florin Iliescu; Marius Rădulescu; Alexandru Mihai Grumezescu; Marius Gabriel Dabija
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

5.  Targeted inhibition of methicillin-resistant Staphylococcus aureus biofilm formation by a graphene oxide-loaded aptamer/berberine bifunctional complex.

Authors:  Yi Ning; Xiaoqi Wang; Pingan Chen; Shiwu Liu; Jue Hu; Rong Xiao; Ling Li; Fangguo Lu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

6.  Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.

Authors:  Lin Wang; Bi-Qiang Zhou; Ying-Hong Li; Qian-Qian Jiang; Wei-Hong Cong; Ke-Ji Chen; Xiao-Min Wen; Zheng-Zhi Wu
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 7.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

8.  Effect of topical berberine in murine cutaneous leishmaniasis lesions.

Authors:  Alba Calvo; Esther Moreno; Irati Aldalur; Carmen Sanmartín; Esther Larrea; Elena González-Peñas; Juan Manuel Irache; Socorro Espuelas
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

9.  Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson's Disease Model.

Authors:  Shuxuan Huang; Hanqun Liu; Yuwan Lin; Muchang Liu; Yanhua Li; Hengxu Mao; Zhiling Zhang; Yunlong Zhang; Panghai Ye; Liuyan Ding; Ziting Zhu; Xinling Yang; Chaojun Chen; Xiaoqin Zhu; Xiaoyun Huang; Wenyuan Guo; Pingyi Xu; Lin Lu
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

Review 10.  Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells.

Authors:  Francisco Alejandro Lagunas-Rangel; Rosa María Bermúdez-Cruz
Journal:  Front Oncol       Date:  2020-11-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.